Cargando…

Engineered T Regulatory Type 1 Cells for Clinical Application

T regulatory cells, a specialized subset of T cells, are key players in modulating antigen (Ag)-specific immune responses in vivo. Inducible T regulatory type 1 (Tr1) cells are characterized by the co-expression of CD49b and lymphocyte-activation gene 3 (LAG-3) and the ability to secrete IL-10, TGF-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gregori, Silvia, Roncarolo, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818395/ https://www.ncbi.nlm.nih.gov/pubmed/29497421 http://dx.doi.org/10.3389/fimmu.2018.00233

Ejemplares similares

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
por: Gregori, Silvia, et al.
Publicado: (2015)

The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
por: Gregori, Silvia, et al.
Publicado: (2012)

The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application
por: Sayitoglu, Ece Canan, et al.
Publicado: (2021)

APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells
por: Pellerin, Laurence, et al.
Publicado: (2018)

Type 1 regulatory T cell-mediated tolerance in health and disease
por: Freeborn, Robert A., et al.
Publicado: (2022)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
por: Cieniewicz, Brandon, et al.
Publicado: (2020)

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome
por: Passerini, Laura, et al.
Publicado: (2011)

Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation
por: Bertaina, Alice, et al.
Publicado: (2019)

Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells
por: Comi, Michela, et al.
Publicado: (2018)

Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4(+)CD25(+)FOXP3(+) Regulatory T-Cells
por: Monti, Paolo, et al.
Publicado: (2008)

BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation
por: Uyeda, Molly Javier, et al.
Publicado: (2021)

Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions
por: Fortunato, Marta, et al.
Publicado: (2021)

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells
por: Rossetti, Maura, et al.
Publicado: (2010)

IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
por: Locafaro, Grazia, et al.
Publicado: (2017)

Engineering Specificity and Function of Therapeutic Regulatory T Cells
por: McGovern, Jenny L., et al.
Publicado: (2017)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

Regulatory B Cells: Role in Type 1 Diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014)

Co-Expression of FOXP3FL and FOXP3Δ2 Isoforms Is Required for Optimal Treg-Like Cell Phenotypes and Suppressive Function
por: Sato, Yohei, et al.
Publicado: (2021)

Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells
por: Dawson, Nicholas A. J., et al.
Publicado: (2017)

The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies
por: Reed, Elaine F., et al.
Publicado: (2022)

An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells
por: Gregori, Silvia, et al.
Publicado: (2005)

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity
por: Solé, Patricia, et al.
Publicado: (2021)

Erratum: Type 1 regulatory T cell-mediated tolerance in health and disease
Publicado: (2023)

Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo
por: Sato, Yohei, et al.
Publicado: (2020)

Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
por: Fuchs, Anke, et al.
Publicado: (2018)

Regulatory T-Cells in Pregnancy: Historical Perspective, State of the Art, and Burning Questions
por: Ruocco, Maria Grazia, et al.
Publicado: (2014)

Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
por: Phillips, Brett Eugene, et al.
Publicado: (2019)

Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes
por: Lu, Jingli, et al.
Publicado: (2017)

Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cells
por: Angelats, Edgar, et al.
Publicado: (2023)

Induction of Antigen-Specific Tolerance in T Cell Mediated Diseases
por: Passerini, Laura, et al.
Publicado: (2020)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

Dendritic cells a double-edge sword in autoimmune responses
por: Amodio, Giada, et al.
Publicado: (2012)

Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes
por: Ben Nasr, Moufida, et al.
Publicado: (2018)

Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells
por: Pohl, Alessandra De Paula, et al.
Publicado: (2020)

Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice
por: Koprivica, Ivan, et al.
Publicado: (2019)

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
por: Magnani, Chiara F, et al.
Publicado: (2011)

Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes
por: Liu, Yikai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cfaijvmssuuk3j9plks1l518os